MedTrace Logo

Optimizing Psychological Treatment for Pain After Breast Cancer

NCT05444101 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 185

Last updated 2022-11-02

No results posted yet for this study

Summary

The present study aims to optimize psychological treatment for pain after breast cancer by identifying active treatment components. Specifically, a factorial design will be used to evaluate the efficacy and change processes of three psychological treatment components, which have been shown to be efficacious in the treatment of pain after breast cancer.

Conditions

Interventions

BEHAVIORAL

Mindful attention

The Mindful attention treatment component consists of a breathing exercise and is operationalized as two sessions (1 hour each) delivered over two weeks, i.e., one session per week, with homework between sessions. Sessions will be delivered online.

BEHAVIORAL

Decentering

The Decentering treatment component consists of a guided imagery exercise and is operationalized as two sessions (1 hour each) delivered over two weeks, i.e., one session per week, with homework between sessions. Sessions will be delivered online.

BEHAVIORAL

Values and committed action

The Values and committed action treatment component consists of identification of personal values and committed action, and is operationalized as two sessions (1 hour each) delivered over two weeks, i.e., one session per week, with homework between sessions. Sessions will be delivered online.

Sponsors & Collaborators

  • Danish Council for Independent Research

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Robert Zachariae, DMSc · University of Aarhus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-10-01
Completion
2024-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05444101 on ClinicalTrials.gov